Nature's Sunshine Products, Inc. (NATR)

Over the past six months, Nature's Sunshine Products' stock price has increased by 45.59%, with a 52-week range between $11.01 and $24.12. Key events impacting the stock include strong third-quarter 2025 results, the appointment of Erich Fritz as Executive Vice President of Global Supply Chain, recognition of Synergy Pro-Argi-9+ as the World's #1 L-Arginine Supplement, a secondary public offering by Fosun Pharma USA, Inc., and significant insider selling in June 2025.

While explicit demand seasonality is not stated, Nature's Sunshine Products' financial reports show quarterly variations in net sales, influenced by factors such as market and channel mix, and the growth of its digital business. Weak demand in North America has negatively impacted top-line performance, while the Asia segment shows positive momentum.

Nature's Sunshine Products, Inc. is a global natural health and wellness company that manufactures and distributes nutritional and personal care products. Founded in 1972 by Gene and Kristine Hughes, it operates in the Consumer Defensive sector, specifically in the Consumer Packaged Goods industry, and is also classified under Pharmaceutical Preparation Manufacturing. The company offers a wide array of products across categories like general health, immune, cardiovascular, digestive, personal care, and weight management, sold under the Nature's Sunshine Products and Synergy WorldWide brands.

Nature's Sunshine Products has a significant international presence, marketing and distributing its products in more than 40 countries. The company's operations are segmented geographically into Asia, Europe, North America, and Latin America/Other, with Asia being its key revenue-generating market.

Nature's Sunshine Products has maintained a reputation for quality and innovation since 1972, emphasizing its commitment to natural health solutions and stringent quality standards. Positive events contributing to its brand reputation include the renewal of a scholarship fund with the David Eccles School of Business, recognition with two Stevie Awards, and being named the World's #1 L-Arginine Supplement. The company focuses on ESG initiatives, including transitioning to 100% solar energy, reducing carbon output, and engaging in packaging reduction and clean product initiatives, and has established the Impact Foundation.

Nature's Sunshine Products has a diverse ownership structure, with institutional investors holding over 60% of the stock as of August 2025. Major institutional shareholders include Vanguard Group Inc., BlackRock, Inc., and Dimensional Fund Advisors LP. Individual insiders hold approximately 5.63% of the shares, while the general public holds about 10.3%. Willem Mesdag is a significant individual owner, and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. recently reduced its stake via a secondary offering.